Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-004866

Interim CEO & General Counsel gave up 6,530 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 20,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2024-01-16 Option exercise +20,834 105,668 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2024-01-16 Shares withheld for taxes −6,530 $8.37 $54,656 99,138 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2024-01-16 Option exercise · Restricted Stock Units −20,834 83,338 D: show line 3 in the form
Loading xslF345X05/tm243610-3_4seq1.xml…